684 related articles for article (PubMed ID: 26232447)
1. Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy?
Sakano S; Inamoto T; Inoue R; Matsumoto H; Nagao K; Yamamoto Y; Azuma H; Matsuyama H
Jpn J Clin Oncol; 2015 Oct; 45(10):968-72. PubMed ID: 26232447
[TBL] [Abstract][Full Text] [Related]
2. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma.
Brien JC; Shariat SF; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD
J Urol; 2010 Jul; 184(1):69-73. PubMed ID: 20478585
[TBL] [Abstract][Full Text] [Related]
3. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; MartÃnez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
[TBL] [Abstract][Full Text] [Related]
5. Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Kobayashi Y; Saika T; Miyaji Y; Saegusa M; Arata R; Akebi N; Takenaka T; Manabe D; Nasu Y; Kumon H
World J Urol; 2012 Apr; 30(2):271-5. PubMed ID: 21805177
[TBL] [Abstract][Full Text] [Related]
6. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
Aboumohamed AA; Krane LS; Hemal AK
J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
[TBL] [Abstract][Full Text] [Related]
7. Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
Kuroiwa K; Inokuchi J; Nishiyama H; Kojima T; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yokomizo A; Matsuyama H; Ichikawa T; Mizusawa J; Eba J; Naito S;
J Urol; 2019 Dec; 202(6):1127-1135. PubMed ID: 31251717
[TBL] [Abstract][Full Text] [Related]
8. Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma.
Ito Y; Kikuchi E; Tanaka N; Miyajima A; Mikami S; Jinzaki M; Oya M
J Urol; 2011 May; 185(5):1621-6. PubMed ID: 21419429
[TBL] [Abstract][Full Text] [Related]
9. Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial.
Ito A; Shintaku I; Satoh M; Ioritani N; Tochigi T; Numata I; Namima T; Kambe K; Kyan A; Ueno S; Katoh S; Adachi H; Yamashita S; Yamaguchi T; Arai Y;
Jpn J Clin Oncol; 2013 Nov; 43(11):1139-44. PubMed ID: 24006504
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
[TBL] [Abstract][Full Text] [Related]
11. Oncological impact of endoscopic bladder cuff management during nephroureterectomy varies according to upper urinary tract tumor location.
Luo HL; Kang CH; Chen YT; Chuang YC; Cheng YT; Lee WC; Chiang PH
Int J Urol; 2014 Apr; 21(4):366-9. PubMed ID: 24118071
[TBL] [Abstract][Full Text] [Related]
12. Prediction of pathological up-staging after radical nephroureterectomy in patients with upper tract urothelial carcinoma.
Shojo K; Takeda T; Akita H; Suzuki T; Mikami S; Shigeta K; Yasumizu Y; Tanaka N; Matsumoto K; Morita S; Kosaka T; Mizuno R; Asanuma H; Jinzaki M; Oya M
World J Urol; 2024 Mar; 42(1):192. PubMed ID: 38530492
[TBL] [Abstract][Full Text] [Related]
13. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.
Messer JC; Terrell JD; Herman MP; Ng CK; Scherr DS; Scoll B; Boorjian SA; Uzzo RG; Wille M; Eggener SE; Lucas SM; Lotan Y; Shariat SF; Raman JD
Urol Oncol; 2013 Aug; 31(6):904-8. PubMed ID: 21906967
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Nakajima Y; Oya M
Urol Oncol; 2014 Jan; 32(1):48.e19-26. PubMed ID: 24055429
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial.
Yamashita S; Ito A; Mitsuzuka K; Ioritani N; Ishidoya S; Ikeda Y; Numahata K; Orikasa K; Tochigi T; Soma F; Namima T; Arai Y
Jpn J Clin Oncol; 2017 Sep; 47(9):870-875. PubMed ID: 28903527
[TBL] [Abstract][Full Text] [Related]
16. Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.
Silberstein JL; Power NE; Savage C; Tarin TV; Favaretto RL; Su D; Kaag MG; Herr HW; Dalbagni G
J Urol; 2012 Feb; 187(2):429-34. PubMed ID: 22177163
[TBL] [Abstract][Full Text] [Related]
17. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984
[TBL] [Abstract][Full Text] [Related]
18. Risk group stratification based on preoperative factors to predict survival after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Sakano S; Matsuyama H; Kamiryo Y; Hayashida S; Yamamoto N; Kaneda Y; Nasu T; Hashimoto O; Joko K; Baba Y; Shimabukuro T; Suga A; Yamamoto M; Aoki A; Takai K; Yoshihiro S; Matsumura M;
Ann Surg Oncol; 2013 Dec; 20(13):4389-96. PubMed ID: 24046115
[TBL] [Abstract][Full Text] [Related]
19. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
Rink M; Ehdaie B; Cha EK; Green DA; Karakiewicz PI; Babjuk M; Margulis V; Raman JD; Svatek RS; Fajkovic H; Lee RK; Novara G; Hansen J; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Fisch M; Scherr DS; Shariat SF; ;
Eur Urol; 2012 Oct; 62(4):677-84. PubMed ID: 22349570
[TBL] [Abstract][Full Text] [Related]
20. Investigating upper urinary tract urothelial carcinomas: a single-centre 10-year experience.
Dev HS; Poo S; Armitage J; Wiseman O; Shah N; Al-Hayek S
World J Urol; 2017 Jan; 35(1):131-138. PubMed ID: 27129575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
